Division of Immunobiology, Children's Hospital Medical Center, Cincinnati, OH 45220, United States; Department of Pediatrics, University of Cincinnati, Cincinnati, OH 45220, United States.
Dept. of Pharmacology & Systems Physiology, University of Cincinnati, Cincinnati, OH 45220, United States.
Brain Behav Immun. 2020 Aug;88:688-698. doi: 10.1016/j.bbi.2020.04.084. Epub 2020 May 4.
Fear-associated conditions such as posttraumatic stress disorder (PTSD) and panic disorder (PD) are highly prevalent. There is considerable interest in understanding contributory risk and vulnerability factors. Accumulating evidence suggests that chronically elevated inflammatory load may be a potential risk factor for these disorders. In this regard, an association of asthma, a chronic inflammatory condition, with PTSD and PD has been reported. Symptoms of PD and PTSD are more prevalent in severe asthmatics, compared to those with mild or moderate asthma suggesting that factors that influence the severity of asthma, may also influence susceptibility to the development of fear-related disorders. There has been relatively little progress in identifying contributory factors and underlying mechanisms, particularly, the translation of severe asthma-associated lung inflammation to central neuroimmune alterations and behavioral manifestations remains unclear. The current study investigated the expression of behaviors relevant to PD and PTSD (CO inhalation and fear conditioning/extinction) in A/J mice using a model of severe allergic asthma associated with a mixed T helper 2 (Th2) and Th17 immune response. We also investigated the accumulation of Th2- and Th17-cytokine expressing cells in lung and brain tissue, microglial alterations, as well as neuronal activation marker, delta FosB (ΔFosB)) in fear and panic regulatory brain areas. HDM-exposed mice elicited higher freezing during fear extinction. CO-associated spontaneous and conditioned freezing, as well as anxiety or depression-relevant exploratory and coping behaviors were not altered by HDM treatment. A significant increase in brain Th17-associated inflammatory mediators was observed prior to behavioral testing, accompanied by microglial alterations in specialized blood brain barrier-compromised circumventricular area, subfornical organ. Post extinction measurements revealed increased ΔFosB staining within the medial prefrontal cortex and basolateral amygdala in HDM-treated mice. Collectively, our data show modulation of brain immune mechanisms and fear circuits by peripheral airway inflammation, and is relevant to understanding the risk and comorbidity of asthma with fear-associated disorders such as PTSD.
与恐惧相关的疾病,如创伤后应激障碍(PTSD)和惊恐障碍(PD),发病率很高。人们非常感兴趣的是了解促成风险和易感性的因素。越来越多的证据表明,慢性炎症负荷升高可能是这些疾病的潜在危险因素。在这方面,已经有报道称,哮喘这种慢性炎症性疾病与 PTSD 和 PD 有关。与轻度或中度哮喘患者相比,PD 和 PTSD 症状在重度哮喘患者中更为常见,这表明影响哮喘严重程度的因素也可能影响发生与恐惧相关的疾病的易感性。在确定促成因素和潜在机制方面,进展相对较少,特别是,将与严重哮喘相关的肺部炎症转化为中枢神经免疫改变和行为表现仍然不清楚。本研究使用与 Th2(辅助性 T 细胞 2)和 Th17 免疫反应混合相关的严重过敏性哮喘模型,在 A/J 小鼠中研究了与 PD 和 PTSD 相关的行为表达(CO 吸入和恐惧条件反射/消退)。我们还研究了 Th2 和 Th17 细胞因子表达细胞在肺部和脑组织中的积累、小胶质细胞改变以及恐惧和惊恐调节脑区中的神经元激活标记物 delta FosB(ΔFosB)。暴露于 HDM 的小鼠在恐惧消退期间表现出更高的冻结。CO 相关的自发和条件性冻结,以及焦虑或抑郁相关的探索和应对行为,不受 HDM 治疗的影响。在进行行为测试之前,观察到大脑 Th17 相关炎症介质显著增加,同时在专门的血脑屏障受损的室周区、穹窿下器官中出现小胶质细胞改变。在 HDM 处理的小鼠中,在消退后测量中发现内侧前额叶皮质和基底外侧杏仁核中的 ΔFosB 染色增加。总的来说,我们的数据表明,外周气道炎症会调节大脑免疫机制和恐惧回路,这与理解哮喘与 PTSD 等与恐惧相关的疾病的风险和共病有关。